-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, K9qPE9BfdBER6Aw24jbdfI/gxSTL8o4GwLx440OfTerb5HdiqbL+wBxju/CV8lpT JX7vzr7gnGFqfUAvxr/Y8A== 0001140361-04-006365.txt : 20041115 0001140361-04-006365.hdr.sgml : 20041115 20041115171911 ACCESSION NUMBER: 0001140361-04-006365 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041110 FILED AS OF DATE: 20041115 DATE AS OF CHANGE: 20041115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DOR BIOPHARMA INC CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1691 MICHIGAN AVE. STREET 2: SUITE 435 CITY: MIAMI STATE: FL ZIP: 33139 BUSINESS PHONE: 305-534-3383 MAIL ADDRESS: STREET 1: 1691 MICHIGAN AVE. STREET 2: SUITE 435 CITY: MIAMI STATE: FL ZIP: 33139 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KESSEL LARRY CENTRAL INDEX KEY: 0001199105 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 041146829 BUSINESS ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584522323X131 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc1.xml FORM 4 X0202 4 2004-11-10 0 0000812796 DOR BIOPHARMA INC DOR 0001199105 KESSEL LARRY 1691 MICHIGAN AVE SUITE 435 MIAMI FL 33139 1 0 0 0 Stock Options (right to buy) .47 2004-11-10 4 A 0 50000 0 A 2004-11-10 2014-11-10 Common Stock 50000 50000 D Stock Options (right to buy) .58 2004-09-09 2007-11-10 Common Stock 50000 50000 D Stock Options (right to buy) .90 2003-09-15 2007-11-10 Common Stock 50000 50000 D Stock Options (right to buy) .85 2003-03-14 2007-11-10 Common Stock 150000 150000 D Stock Options (right to buy) .20 2002-10-23 2007-11-10 Common Stock 100000 100000 D Stock Options (right to buy) .25 2002-06-29 2007-11-10 Common Stock 50000 50000 D The date the stock options are exercisable was reduced to 3 years from date of acceptance of resignation on November 10, 2004. /s/ Lawrence Kessel 2004-11-15 -----END PRIVACY-ENHANCED MESSAGE-----